Inhibitory effect of levocabastine on allergen‐induced increase of nasal reactivity to histamine and cell influx
- 1 November 1993
- Vol. 48 (8) , 598-601
- https://doi.org/10.1111/j.1398-9995.1993.tb00755.x
Abstract
For evaluation of the effect of levocabastine pretreatment on allergen-induced rhinitis symptoms, changes in nasal washings, and nasal responsiveness to histamine, 12 asymptomatic patients with documented allergic rhinitis participated in a single-blind, placebo-controlled study. Eight-day treatment with levocabastine (twice in each nostril, four times a day) caused significant reduction in nasal symptoms and inflammatory cell influx after allergen challenge, as compared with placebo administration. Levocabastine inhibited increased nasal reactivity to histamine induced by allergen provocation, as controlled by rhinitis symptoms and albumin level in nasal washings. These data reveal a high effectiveness of levocabastine in the prevention of allergen-induced rhinitis symptoms. Moreover, its inhibitory effect on inflammatory cell influx and hyperresponsiveness to histamine suggest that levocabastine is more than a simple H1-receptor antagonist.Keywords
This publication has 7 references indexed in Scilit:
- Antigen-provoked Increase in Histamine Reactivity: Observations on MechanismsAmerican Review of Respiratory Disease, 1991
- Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influxJournal of Allergy and Clinical Immunology, 1990
- The‘nasal pool’device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretionsClinical and Experimental Allergy, 1990
- Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivoClinical and Experimental Allergy, 1987
- Comparison of levocabastine, a new selective H1‐receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.British Journal of Clinical Pharmacology, 1986
- Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response*Journal of Allergy and Clinical Immunology, 1986
- Levocabastine (R 50547): The prototype of a chemical series of compounds with specific H1‐antihistaminic activityDrug Development Research, 1986